Review

Butyrate affects bacterial virulence: a new perspective on preventing enteric bacterial pathogen invasion

Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212008, China

Department of Biochemistry & Molecular Biology, Jiangsu University School of Medicine, Zhenjiang, Jiangsu, 212013, China

Search for more papers by this author

Hao Tang

Department of Biochemistry & Molecular Biology, Jiangsu University School of Medicine, Zhenjiang, Jiangsu, 212013, China

Search for more papers by this author

Xinxiang Huang

Department of Biochemistry & Molecular Biology, Jiangsu University School of Medicine, Zhenjiang, Jiangsu, 212013, China

Search for more papers by this author

Min Xu

*Author for correspondence:

E-mail Address: peterxu1974@163.com

Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212008, China

Institute of Digestive Diseases, Jiangsu University, Zhenjiang, Jiangsu, 212013, China

Search for more papers by this author

Published Online:12 Dec 2023https://doi.org/10.2217/fmb-2023-0148

View article

Abstract

Enteric bacterial pathogens are a major threat to intestinal health. With the widespread use of antibiotics, bacterial resistance has become a problem, and there is an urgent need for a new treatment to reduce dependence on antibiotics. Butyrate can control enteric bacterial pathogens by regulating the expression of their virulence genes, promoting the posttranslational modification of their proteins, maintaining an anaerobic environment, regulating the host immune system and strengthening the intestinal mucosal barrier. Here, this review describes the mechanisms by which butyrate regulates the pathogenicity of enteric bacterial pathogens from various perspectives and discusses the prospects and limitations of butyrate as a new option for the control of pathogenic bacteria.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Teklemariam AD, Al-Hindi RR, Albiheyri RS et al. Human salmonellosis: a continuous global threat in the farm-to-fork food safety continuum. Foods 12(9), 1756 (2023).
Medline CASGoogle Scholar
2. Buliva E, Elnossery S, Okwarah P et al. Cholera prevention, control strategies, challenges and World Health Organization initiatives in the Eastern Mediterranean Region: a narrative review. Heliyon 9(5), e15598 (2023).
MedlineGoogle Scholar
3. Christaki E, Marcou M, Tofarides A. Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence. J. Mol. Evol. 88(1), 26–40 (2020). • Antimicrobial resistance in bacteria, caused by the overuse of antibiotics, has become a global problem. It is therefore important to develop new strategies to prevent bacterial infections.
Medline CASGoogle Scholar
4. Mazhar M, Zhu Y, Qin L. The interplay of dietary fibers and intestinal microbiota affects type 2 diabetes by generating short-chain fatty acids. Foods 12(5), 1023 (2023).
Medline CASGoogle Scholar
5. Dong Y, Zhang K, Wei J et al. Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy? Front. Immunol. 14, 1158200 (2023).
Medline CASGoogle Scholar
6. Li Y, Zhang Y, Wei K et al. Review: effect of gut microbiota and its metabolite SCFAs on radiation-induced intestinal injury. Front. Cell. Infect. Microbiol. 11, 577236 (2021).
Medline CASGoogle Scholar
7. Zhan Z, Tang H, Zhang Y et al. Potential of gut-derived short-chain fatty acids to control enteric pathogens. Front. Microbiol. 13, 976406 (2022).
MedlineGoogle Scholar
8. Tang H, Zhan Z, Zhang Y, Huang X. Propionylation of lysine, a new mechanism of short-chain fatty acids affecting bacterial virulence. Am. J. Transl. Res. 14(8), 5773–5784 (2022).
Medline CASGoogle Scholar
9. Fang Y, Li X. Protein lysine four-carbon acylations in health and disease. J. Cell Physiol. doi: 10.1002/jcp.30981 (2023) (Epub ahead of print).
Google Scholar
10. Xiang T, Zhao S, Wu Y et al. Novel post-translational modifications in the kidneys for human health and diseases. Life Sci. 311(Pt B), 121188 (2022).
Medline CASGoogle Scholar
11. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285), 59–65 (2010).
Medline CASGoogle Scholar
12. Litvak Y, Byndloss MX, Bäumler AJ. Colonocyte metabolism shapes the gut microbiota. Science 362(6418), eaat9076 (2018).
MedlineGoogle Scholar
13. Golpour F, Abbasi-Alaei M, Babaei F et al. Short chain fatty acids, a possible treatment option for autoimmune diseases. Biomed. Pharmacother. 163, 114763 (2023).
Medline CASGoogle Scholar
14. Parada Venegas D, De La Fuente MK, Landskron G et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 10, 277 (2019).
MedlineGoogle Scholar
15. Cronin P, Joyce SA, O'Toole PW, O'Connor EM. Dietary fibre modulates the gut microbiota. Nutrients 13(5), 1655 (2021). • Dietary fiber in the intestine is fermented by the intestinal flora to produce short-chain fatty acids, and a reasonable concentration of short-chain fatty acids in the intestine benefits the intestinal health.
Medline CASGoogle Scholar
16. Ríos-Covián D, Ruas-Madiedo P, Margolles A et al. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol. 7, 185 (2016).
MedlineGoogle Scholar
17. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7(3), 189–200 (2016).
MedlineGoogle Scholar
18. Singh V, Lee G, Son H et al. Butyrate producers, ‘the sentinel of gut’: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front. Microbiol. 13, 1103836 (2022).
MedlineGoogle Scholar
19. Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio 5(2), e00889 (2014).
MedlineGoogle Scholar
20. Fu X, Liu Z, Zhu C et al. Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria. Crit. Rev. Food Sci. Nutr. 59(Suppl. 1), S130–S152 (2019).
Medline CASGoogle Scholar
21. Stilling RM, Van De Wouw M, Clarke G et al. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem. Int. 99, 110–132 (2016).
Medline CASGoogle Scholar
22. Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19(1), 29–41 (2017).
Medline CASGoogle Scholar
23. Vital M, Karch A, Pieper DH. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems 2(6), e00130-17 (2017).
MedlineGoogle Scholar
24. Zhang L, Liu C, Jiang Q, Yin Y. Butyrate in energy metabolism: there is still more to learn. Trends Endocrinol. Metab. 32(3), 159–169 (2021).
Medline CASGoogle Scholar
25. Louis P, Duncan SH, Mccrae SI et al. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J. Bacteriol. 186(7), 2099–2106 (2004).
Medline CASGoogle Scholar
26. Vital M, Penton CR, Wang Q et al. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome 1(1), 8 (2013).
MedlineGoogle Scholar
27. Clausen MR, Mortensen PB. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut 37(5), 684–689 (1995).
Medline CASGoogle Scholar
28. Nie K, Ma K, Luo W et al. Roseburia intestinalis: a beneficial gut organism from the discoveries in genus and species. Front. Cell Infect. Microbiol. 11, 757718 (2021).
Medline CASGoogle Scholar
29. Stokowa-Sołtys K, Wojtkowiak K, Jagiełło K. Fusobacterium nucleatum – friend or foe? J. Inorg. Biochem. 224, 111586 (2021).
Medline CASGoogle Scholar
30. Bronner DN, Faber F, Olsan EE et al. Genetic ablation of butyrate utilization attenuates gastrointestinal Salmonella disease. Cell Host Microbe 23(2), 266–273.e4 (2018).
Medline CASGoogle Scholar
31. Rishi P, Pathak S, Ricke SC. Short chain fatty acids influence virulence properties of Salmonella enterica serovar typhimurium. J. Environ. Sci. Health B 40(4), 645–657 (2005).
Medline CASGoogle Scholar
32. Durant JA, Lowry VK, Nisbet DJ et al. Short-chain fatty acids affect cell-association and invasion of HEp-2 cells by Salmonella typhimurium. J. Environ. Sci. Health B 34(6), 1083–1099 (1999).
Medline CASGoogle Scholar
33. Gantois I, Ducatelle R, Pasmans F et al. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl. Environ. Microbiol. 72(1), 946–949 (2006).
Medline CASGoogle Scholar
34. Boyen F, Haesebrouck F, Vanparys A et al. Coated fatty acids alter virulence properties of Salmonella Typhimurium and decrease intestinal colonization of pigs. Vet. Microbiol. 132(3–4), 319–327 (2008).
Medline CASGoogle Scholar
35. Van Immerseel F, De Buck J, De Smet I et al. Interactions of butyric acid- and acetic acid-treated Salmonella with chicken primary cecal epithelial cells in vitro. Avian Dis. 48(2), 384–391 (2004).
MedlineGoogle Scholar
36. Papezova K, Gregorova D, Jonuschies J, Rychlik I. Ordered expression of virulence genes in Salmonella enterica serovar Typhimurium. Folia Microbiol (Praha) 52(2), 107–114 (2007).
Medline CASGoogle Scholar
37. Liu J, Zhu W, Qin N et al. Propionate and butyrate inhibit biofilm formation of Salmonella Typhimurium grown in laboratory media and food models. Foods 11(21), 3493 (2022). •• Butyrate inhibits arcZ expression and thus affects biofilm formation by Salmonella typhimurium.
Medline CASGoogle Scholar
38. Goodman KN, Powers MJ, Crofts AA et al. Campylobacter jejuni BumSR directs a response to butyrate via sensor phosphatase activity to impact transcription and colonization. Proc. Natl Acad. Sci. USA 117(21), 11715–11726 (2020).
Medline CASGoogle Scholar
39. Sun Y, Wilkinson BJ, Standiford TJ et al. Fatty acids regulate stress resistance and virulence factor production for Listeria monocytogenes. J. Bacteriol. 194(19), 5274–5284 (2012).
Medline CASGoogle Scholar
40. Pace F, Rudolph SE, Chen Y et al. The short-chain fatty acids propionate and butyrate augment adherent-invasive Escherichia coli virulence but repress inflammation in a human intestinal enteroid model of infection. Microbiol. Spectr. 9(2), e0136921 (2021). • Butyrate upregulates the flagellar and pilus assembly genes of adherent-invasive Escherichia coli to improve bacterial adhesion and invasion.
MedlineGoogle Scholar
41. Nakanishi N, Tashiro K, Kuhara S et al. Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology (Reading) 155(Pt 2), 521–530 (2009).
Medline CASGoogle Scholar
42. Tobe T, Nakanishi N, Sugimoto N. Activation of motility by sensing short-chain fatty acids via two steps in a flagellar gene regulatory cascade in enterohemorrhagic Escherichia coli. Infect. Immun. 79(3), 1016–1024 (2011).
Medline CASGoogle Scholar
43. Takao M, Yen H, Tobe T. LeuO enhances butyrate-induced virulence expression through a positive regulatory loop in enterohaemorrhagic Escherichia coli. Mol. Microbiol. 93(6), 1302–1313 (2014).
Medline CASGoogle Scholar
44. Dillon SC, Espinosa E, Hokamp K et al. LeuO is a global regulator of gene expression in Salmonella enterica serovar Typhimurium. Mol. Microbiol. 85(6), 1072–1089 (2012).
Medline CASGoogle Scholar
45. Baek C-H, Wang S, Roland KL, Curtiss R. Leucine-responsive regulatory protein (Lrp) acts as a virulence repressor in Salmonella enterica serovar Typhimurium. J. Bacteriol. 191(4), 1278–1292 (2009).
Medline CASGoogle Scholar
46. Qin R, Sang Y, Ren J et al. The bacterial two-hybrid system uncovers the involvement of acetylation in regulating of Lrp activity in Salmonella Typhimurium. Front. Microbiol. 7, 1864 (2016).
MedlineGoogle Scholar
47. Walsh CT, Garneau-Tsodikova S, Gatto GJ. Protein posttranslational modifications: the chemistry of proteome diversifications. Angew. Chem. Int. Ed. Engl. 44(45), 7342–7372 (2005).
Medline CASGoogle Scholar
48. Minguez P, Parca L, Diella F et al. Deciphering a global network of functionally associated post-translational modifications. Mol. Syst. Biol. 8, 599 (2012).
MedlineGoogle Scholar
49. Ren J, Sang Y, Lu J, Yao Y-F. Protein acetylation and its role in bacterial virulence. Trends Microbiol. 25(9), 768–779 (2017).
Medline CASGoogle Scholar
50. Liu M, Guo L, Fu Y et al. Bacterial protein acetylation and its role in cellular physiology and metabolic regulation. Biotechnol. Adv. 53, 107842 (2021).
Medline CASGoogle Scholar
51. Hentchel KL, Escalante-Semerena JC. Acylation of biomolecules in prokaryotes: a widespread strategy for the control of biological function and metabolic stress. Microbiol. Mol. Biol. Rev. 79(3), 321–346 (2015).
MedlineGoogle Scholar
52. Chen Y, Sprung R, Tang Y et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell Proteomics 6(5), 812–819 (2007).
Medline CASGoogle Scholar
53. Sang Y, Ren J, Qin R et al. Acetylation regulating protein stability and DNA-binding ability of HilD, thus modulating Salmonella Typhimurium virulence. J. Infect. Dis. 216(8), 1018–1026 (2017). •• Modification by acylation changes the stability and DNA-binding ability of HilD protein, the key virulence regulator of Salmonella Typhimurium, thereby affecting its virulence.
Medline CASGoogle Scholar
54. Zhang ZJ, Pedicord VA, Peng T, Hang HC. Site-specific acylation of a bacterial virulence regulator attenuates infection. Nat. Chem. Biol. 16(1), 95–103 (2020). •• Site-specific butyrylation of the transcriptional regulator HilA of Salmonella pathogenicity island 1 inhibits bacterial pathogenesis.
MedlineGoogle Scholar
55. Xu J-Y, Xu Z, Liu X et al. Protein acetylation and butyrylation regulate the phenotype and metabolic shifts of the endospore-forming Clostridium acetobutylicum. Mol. Cell Proteomics 17(6), 1156–1169 (2018).
Medline CASGoogle Scholar
56. Gupta VK, Paul S, Dutta C. Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front. Microbiol. 8, 1162 (2017).
MedlineGoogle Scholar
57. Rivera-Chávez F, Lopez CA, Bäumler AJ. Oxygen as a driver of gut dysbiosis. Free Radic. Biol. Med. 105, 93–101 (2017).
Medline CASGoogle Scholar
58. Kelly CJ, Zheng L, Campbell EL et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5), 662–671 (2015).
Medline CASGoogle Scholar
59. Nagpal R, Tsuji H, Takahashi T et al. Ontogenesis of the gut microbiota composition in healthy, full-term, vaginally born and breast-fed infants over the first 3 years of life: a quantitative bird's-eye view. Front. Microbiol. 8, 1388 (2017).
MedlineGoogle Scholar
60. Kim S, Covington A, Pamer EG. The intestinal microbiota: antibiotics, colonization resistance, and enteric pathogens. Immunol. Rev. 279(1), 90–105 (2017).
Medline CASGoogle Scholar
61. Pamer EG. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352(6285), 535–538 (2016).
Medline CASGoogle Scholar
62. Garner CD, Antonopoulos DA, Wagner B et al. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect. Immun. 77(7), 2691–2702 (2009).
Medline CASGoogle Scholar
63. Rivera-Chávez F, Zhang LF, Faber F et al. Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella. Cell Host Microbe 19(4), 443–454 (2016).
Medline CASGoogle Scholar
64. Galán JE. Salmonella Typhimurium and inflammation: a pathogen-centric affair. Nat. Rev. Microbiol. 19(11), 716–725 (2021).
Medline CASGoogle Scholar
65. Stecher B, Robbiani R, Walker AW et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5(10), 2177–2189 (2007).
Medline CASGoogle Scholar
66. Mirzaei R, Dehkhodaie E, Bouzari B et al. Dual role of microbiota-derived short-chain fatty acids on host and pathogen. Biomed. Pharmacother. 145, 112352 (2022).
Medline CASGoogle Scholar
67. Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat. Rev. Gastroenterol. Hepatol. 16(8), 461–478 (2019).
MedlineGoogle Scholar
68. Liu H, Wang J, He T et al. Butyrate: a double-edged sword for health? Adv Nutr 9(1), 21–29 (2018).
Medline CASGoogle Scholar
69. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14(10), 667–685 (2014).
Medline CASGoogle Scholar
70. Gupta A, Bansal M, Liyanage R et al. Sodium butyrate modulates chicken macrophage proteins essential for Salmonella enteritidis invasion. PLoS ONE 16(4), e0250296 (2021). •• Butyrate upregulates the production of vimentin protein in chicken macrophage cells, which is involved in the clearance of intestinal pathogens.
Medline CASGoogle Scholar
71. Tsugawa H, Kabe Y, Kanai A et al. Short-chain fatty acids bind to apoptosis-associated speck-like protein to activate inflammasome complex to prevent Salmonella infection. PLoS Biol. 18(9), e3000813 (2020).
Medline CASGoogle Scholar
72. Song C, Chai Z, Chen S et al. Intestinal mucus components and secretion mechanisms: what we do and do not know. Exp. Mol. Med. 55(4), 681–691 (2023).
Medline CASGoogle Scholar
73. Martens EC, Neumann M, Desai MS. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16(8), 457–470 (2018).
Medline CASGoogle Scholar
74. Zhao Y, Chen F, Wu W et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 11(3), 752–762 (2018).
Medline CASGoogle Scholar
75. Fang J, Wang H, Zhou Y et al. Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis. Exp. Mol. Med. 53(5), 772–787 (2021).
Medline CASGoogle Scholar
76. Dahlgren D, Lennernäs H. Review on the effect of chemotherapy on the intestinal barrier: epithelial permeability, mucus and bacterial translocation. Biomed. Pharmacother. 162, 114644 (2023).
Medline CASGoogle Scholar
77. Sylvester PA, Myerscough N, Warren BF et al. Differential expression of the chromosome 11 mucin genes in colorectal cancer. J. Pathol. 195(3), 327–335 (2001).
Medline CASGoogle Scholar
78. Gratchev A, Böhm C, Riede E et al. Regulation of mucin MUC2 gene expression during colon carcinogenesis. Ann. NY Acad. Sci. 859, 180–183 (1998).
Medline CASGoogle Scholar
79. Gaudier E, Jarry A, Blottière HM et al. Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am. J. Physiol. Gastrointest. Liver Physiol. 287(6), G1168–G1174 (2004).
Medline CASGoogle Scholar
80. Burger-Van Paassen N, Vincent A, Puiman PJ et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem. J. 420(2), 211–219 (2009).
MedlineGoogle Scholar
81. Wrzosek L, Miquel S, Noordine M-L et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11, 61 (2013).
MedlineGoogle Scholar
82. Wang H-B, Wang P-Y, Wang X et al. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig. Dis. Sci. 57(12), 3126–3135 (2012).
Medline CASGoogle Scholar

Vol. 19, No. 1

Metrics

Downloaded 85 times

History

Received 29 June 2023

Accepted 11 September 2023

Published online 12 December 2023

Published in print January 2024

Information

Keywords

Author contributions

X Liu drafted the manuscript. H Tang, X Huang and M Xu critically reviewed and revised the manuscript. All authors approved the final manuscript.

Acknowledgments

The authors thank International Science Editing (http://www.internationalscience-editing.com) for English language editing. The authors thank Biorender for providing the professionally designed figure elements for this article.

Financial disclosure

This study was supported by the National Natural Science Foundation of China (82072754) and the Natural Science Research of Jiangsu Higher Education Institutions of China (20KJA310006). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

No writing assistance was utilized in the production of this manuscript.

PDF download